doi:10.12300/j.issn.1674-5817.2025.213

Abstract

CLC Number:

Q95-33

References 16

[1]	孙强. 无替代,何谈取消[J]. 实验动物与比较医学, 2025, 45(3): 376-378. DOI: 10.12300/j.issn.1674-5817.2025.064 .
[2]	孙强. 非动物实验替代知多少[J]. 实验动物与比较医学, 2025, 45(4): 508-513. DOI: 10.12300/j.issn.1674-5817.2025.117 .
[3]	孙强. 中国实验猴产业的历史、现状、挑战与机遇[J]. 实验动物与比较医学, 2024, 44(4): 343-356. DOI: 10.12300/j.issn.1674-5817.2024.112 .
[4]	SCHÜRCH C M. Therapeutic antibodies for myeloid neoplasms-current developments and future directions[J]. Front Oncol, 2018, 18(8): 152. DOI: 10.3389/fonc.2018.00152 .
[5]	ADASHI E Y, O'MAHONY D P, COHEN I G. The FDA modernization act 2.0: drug testing in animals is rendered optional[J]. Am J Med, 2023, 136(9): 853-854. DOI: 10.1016/j.amjmed.2023.03.033 .
[6]	FDA. FDA announces plan to phase out animal testing requirement for monoclonal antibodies and other drugs[EB/OL]. (2025-04-10)[2025-09-15]. .
[7]	EFFER B, PEREZ I, ULLOA D, et al. Therapeutic targets of monoclonal antibodies used in the treatment of cancer: current and emerging[J]. Biomedicines, 2023, 11(7): 2086. DOI: 10.3390/biomedicines11072086 .
[8]	LEUNG C, JESSEN B, RATTEL B, et al. Considerations of non-human primate use in nonclinical toxicity study package for oncology therapeutics with well-characterized target in supports of 3Rs - an IQ DruSafe industry survey[J]. Regul Toxicol Pharmacol, 2025, 162: 105902. DOI: 10.1016/j.yrtph. 2025.105902 .
[9]	CHIEN H T, PRIOR H, ANDREWS L, et al. Re-evaluating the need for chronic toxicity studies with therapeutic monoclonal antibodies, using a weight of evidence approach[J]. Regul Toxicol Pharmacol, 2023, 138: 105329. DOI: 10.1016/j.yrtph.2022.105329 .
[10]	RALSTON S L, LI L, LEE D, et al. Strategies to reduce the use of non-human primates in development of oncology ADCs with cytotoxic payloads[J]. Regul Toxicol Pharmacol, 2025, 162: 105887. DOI: 10.1016/j.yrtph.2025.105887 .
[11]	KHONGORZUL P, LING C J, KHAN F U, et al. Antibody-drug conjugates: a comprehensive review[J]. Mol Cancer Res, 2020, 18(1): 3-19. DOI: 10.1158/1541-7786.MCR-19-0582 .
[12]	RICCARDI F, BO M DAL, MACOR P, et al. A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy[J]. Front Pharmacol, 2023, 14: 1274088. DOI: 10.3389/fphar.2023.1274088 .
[13]	DRAGO J Z, MODI S, CHANDARLAPATY S. Unlocking the potential of antibody-drug conjugates for cancer therapy[J]. Nat Rev Clin Oncol, 2021, 18(6): 327-344. DOI: 10.1038/s41571-021-00470-8 .
[14]	CONNORS J M, JURCZAK W, STRAUS D J, et al. Brentuximab vedotin with chemotherapy for stage Ⅲ or Ⅳ Hodgkin's lymphoma[J]. N Engl J Med, 2018, 378(4): 331-344. DOI: 10.1056/nejmoa1708984 .
[15]	COLOMBO R, RICH J R. The therapeutic window of antibody drug conjugates: a dogma in need of revision[J]. Cancer Cell, 2022, 40(11): 1255-1263. DOI: 10.1016/j.ccell.2022.09.016 .
[16]	NEFF-LAFORD H D, CARRATT S A, CAROSINO C, et al. The vedotin antibody-drug conjugate payload drives platform-based nonclinical safety and pharmacokinetic profiles[J]. Mol Cancer Ther, 2024, 23(10): 1483-1493. DOI: 10.1158/1535-7163.mct-24-0087 .

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 16

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	ZHANG Jiaoling, LIN Aping, XU Shiying, PAN Dequan, CAI Yijun. Optimization and Application of Mouse Embryo Transfer Technology [J]. Laboratory Animal and Comparative Medicine, 2026, (): 1-9.
[2]	. [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 611-613.
[3]	MA Wenjing, LIU Yanping, LI Yifan, GUO Huan, XIE Lihui, DU Longji, MA Jiali, WANG Hongping, LI Jiamin. Practice in Validity Period Management of Disinfectants, Feed, and Bedding in Laboratory Animal Facilities under Good Laboratory Practice Management System [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 593-603.
[4]	WANG Lu, WANG Qingjie, YANG Chunhong, ZHANG Yijian. Application of New Approach Methodologies in Biomedical Field and Their Implementation of "3R" Principle [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 573-582.
[5]	QIANG Sujing, LI Dongting, XU Jinhua, CAI Li, WEI Siyu, ZOU Jialei, DING Yuqiang. Identification and Analysis of the Klebsiella pneumoniae Species Complex in Laboratory Rats and Mice [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 564-572.
[6]	LI Hongman, CHEN Yutong, SHI Yingpei, WANG Yijing, PAN Yan, XU Tong, ZHOU Yi, DENG Qiyue, LIU Xue. A New Perspective on Mental Health Assessment in Laboratory Animals: Stress Response Monitoring Based on Hair Characteristics [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 553-563.
[7]	LEI Jianjun, SUO Chenhao, ZHANG He. Resveratrol Alleviates Blood‑Brain Barrier Damage in Cerebral Ischemia‑Reperfusion Rat Models through Modulation of the CCL3/CCR5 Signaling Pathway [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 487-497.
[8]	LI Chunyang, LIU Xingchen, LI Yuzhuo, LU Yong, WANG Yan, GAO Changshan, NIE Yanhong, BIAN Xinyan, HU Chao, ZHU Jiaqiao, SUN Qiang. Generation of Cynomolgus and Rhesus Monkey Models Carrying the BMPR1B^FecB Variant [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 467-475.
[9]	LIU Liang, CHEN Bin, MEN Li, ZHANG Huan, LIU Jinzhou, LIU Keliang, LI Yangyou, DUAN Jiahui, YAN Jintai, YANG Guolin, JIN Bo. Serving National Strategies and the Chengdu-Chongqing Biomedical Industry: Innovative Layout and Practical Pathways of Undergraduate Education in Laboratory Animal Science [J]. Laboratory Animal and Comparative Medicine, 2026, (): 1-12.
[10]	YANG Ran, FENG Jiwei, MA Fei, ZHANG Yu, LIU Zhiwei, JIIN Lilun. Fraxetin Inhibits Ferroptosis and Alleviates Cartilage Damage in Osteoarthritis Rat Through Nrf2/HO-1 Signaling Pathway [J]. Laboratory Animal and Comparative Medicine, 2026, (): 1-12.
[11]	AI Xiufeng, ZHANG Lizong, FANG Mingsun, LÜ Dongying, CHEN Chu, CAI Zhaowei, WANG Dejun. Analysis of Differences in the Intestinal Flora of Rats and Mice after Drinking Chlorinated Water Based on 16S rRNA Sequencing [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 437-445.
[12]	ZHOU Yimin, ZHANG Xinyu, YANG Jianuo, LIU Mengjia, SI Cancan, YE Hailü, SUN Wenchao, LAN Tian. Development of a Triplex TaqMan Quantitative PCR Method for Simultaneous Detection of MHV, MPV, and Reo-3 [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 408-415.
[13]	. [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 464-466.
[14]	CHEN Lin, ZHANG Housen, AI Man, QI Chongyang. Research on the High-Quality Development Path of Laboratory Animal Management in Jiangsu Province Empowered by Digital Transformation [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 426-436.
[15]	LI Longxue, WAN Chongfan, ZHANG Qi, LEI Ruting, WANG Xiaoyue, CHENG Leyan, LAI Qi, LIU Ronghua, LIU Xuan, XU Tielong. Molecular Mechanisms of Qingfei Paidu Decoction in the Prevention and Treatment of Acute Lung Injury in Mice Based on miRNA Sequencing [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 311-320.